Aldeyra Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Lexington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Aldeyra Therapeutics, Inc. has filed 645 SEC EDGAR filings since 06 Oct 2005

SEC filing history

Showing 151-175 of 643 matching filings.

Per page
25
Current page
7
DEF 14A File 001-36332

DEF 14A

Filing date
23 May 2023
Reporting date
30 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
04 May 2023
Reporting date
04 May 2023
Next action
Verify source filing
S-8 File 333-270401

S-8

Filing date
09 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
09 Mar 2023
Reporting date
09 Mar 2023
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2023
Reporting date
28 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2023
Reporting date
28 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Mar 2023
Reporting date
28 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
02 Mar 2023
Reporting date
02 Mar 2023
Next action
Verify source filing
SC 13G/A File 005-88182

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
07 Feb 2023
Reporting date
07 Feb 2023
Next action
Verify source filing
SC 13G/A File 005-88182

SC 13G/A filing

Filing date
03 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
27 Dec 2022
Reporting date
22 Dec 2022
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
21 Dec 2022
Reporting date
21 Dec 2022
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
01 Dec 2022
Reporting date
01 Dec 2022
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
29 Nov 2022
Reporting date
29 Nov 2022
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
10 Nov 2022
Reporting date
10 Nov 2022
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
06 Oct 2022
Reporting date
06 Oct 2022
Next action
Verify source filing
8-K File 001-36332

ALDEYRA THERAPEUTICS, INC. 8-K

Filing date
14 Sep 2022
Reporting date
14 Sep 2022
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
11 Aug 2022
Reporting date
09 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
10 Aug 2022
Reporting date
08 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .